Simethicone retinopathy in an immature infant

Annie Chan1, Tony Tsai, Joan O'Brien

  • 1Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.

Insights

Simethicone, an over-the-counter colic medication, may cause retinal lesions in infants. These findings suggest an embolic phenomenon possibly linked to systemic drug absorption.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Pharmacology

Background:

  • Colic is a common issue in infants.
  • Simethicone is a widely used over-the-counter medication for infant colic.
  • Systemic absorption of medications in infants can lead to various complications.

Observation:

  • Retinal findings were observed in an immature infant.
  • The infant was consuming simethicone for colic treatment.
  • The observed retinal lesions were consistent with an embolic phenomenon.

Findings:

  • The retinal lesions suggest an embolic event.
  • Systemic absorption of simethicone is a potential cause.
  • This case highlights a possible adverse effect of simethicone in infants.

Implications:

  • This case may inform clinical practice regarding simethicone use in infants.
  • Further research is needed to confirm the link between simethicone and retinal emboli.
  • Awareness of potential ocular complications is crucial for pediatricians and ophthalmologists.